Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Annals of Hematology|June 17, 2019
Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemiaMasamitsu Yanada, Jinichi Mori, Jun Aoki, et al.
Transplantation and Cellular Therapy|April 8, 2021
Prognostic Impact of the Fractionation of Total Body Irradiation for Patients with Acute Myeloid Leukemia Undergoing Myeloablative Allogeneic Hematopoietic Cell TransplantationNorihiro Ueda, Takaaki Konuma, Jun Aoki, et al.
Bone Marrow Transplantation|February 6, 2019
Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantationHidehiro Itonaga, Ken Ishiyama, Kazunari Aoki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 6, 2019
Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell TransplantationKaito Harada, Takaaki Konuma, Shinichiro Machida, et al.
International Journal of Hematology|January 27, 2023
Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three casesTakanori Fukuta, Takashi Tanaka, Taiki Hashimoto, et al.
Respiratory Investigation|November 6, 2025
Familial fibrotic hypersensitivity pneumonitis: A distinct clinical phenotype with shorter leukocyte telomere lengthMasashi Nishimura, Hideya Kitamura, Yoichi Tagami, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2017
Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplantation Recipients 50 Years or OlderKoji Kawamura, Shinichi Kako, Shuichi Mizuta, et al.
Annals of Hematology|March 12, 2019
Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69 years with myelodysplastic syndromeHidehiro Itonaga, Ken Ishiyama, Kazunari Aoki, et al.
American Journal of Hematology|December 15, 2015
Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemiaJun Aoki, Heiwa Kanamori, Masatsugu Tanaka, et al.
Ejhaem|February 23, 2023
Outcomes after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with der(1;7)(q10;p10)Hiroki Mizumaki, Ken Ishiyama, Jun Aoki, et al.
Pageof 17